163 related articles for article (PubMed ID: 3999002)
1. Solubilization by cosolvents I: organic solutes in propylene glycol-water mixtures.
Yalkowsky SH; Rubino JT
J Pharm Sci; 1985 Apr; 74(4):416-21. PubMed ID: 3999002
[TBL] [Abstract][Full Text] [Related]
2. Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect.
Miyako Y; Khalef N; Matsuzaki K; Pinal R
Int J Pharm; 2010 Jun; 393(1-2):48-54. PubMed ID: 20363302
[TBL] [Abstract][Full Text] [Related]
3. Excess free energy approach to the estimation of solubility in mixed solvent systems III: Ethanol-propylene glycol-water mixtures.
Williams NA; Amidon GL
J Pharm Sci; 1984 Jan; 73(1):18-23. PubMed ID: 6694075
[TBL] [Abstract][Full Text] [Related]
4. Prediction of drug solubility in water-propylene glycol mixtures using Jouyban-Acree model.
Jouyban A
Pharmazie; 2007 May; 62(5):365-7. PubMed ID: 17557745
[TBL] [Abstract][Full Text] [Related]
5. Solubilization by cosolvents. Establishing useful constants for the log-linear model.
Millard J; Alvarez-Núñez F; Yalkowsky S
Int J Pharm; 2002 Oct; 245(1-2):153-66. PubMed ID: 12270252
[TBL] [Abstract][Full Text] [Related]
6. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents.
Kawakami K; Oda N; Miyoshi K; Funaki T; Ida Y
Eur J Pharm Sci; 2006 May; 28(1-2):7-14. PubMed ID: 16406526
[TBL] [Abstract][Full Text] [Related]
7. Solubility prediction of paracetamol in water-ethanol-propylene glycol mixtures at 25 and 30 degrees C using practical approaches.
Jouyban A; Azarmir O; Mirzaei S; Hassanzadeh D; Ghafourian T; Acree WE; Nokhodchi A
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):602-6. PubMed ID: 18379118
[TBL] [Abstract][Full Text] [Related]
8. A new definition of solubilization power of a cosolvent.
Jouyban A; Fakhree MA
Pharmazie; 2008 Apr; 63(4):317-9. PubMed ID: 18468394
[TBL] [Abstract][Full Text] [Related]
9. Cosolvency and deviations from log-linear solubilization.
Rubino JT; Yalkowsky SH
Pharm Res; 1987 Jun; 4(3):231-6. PubMed ID: 3509286
[TBL] [Abstract][Full Text] [Related]
10. Solubilization of rapamycin.
Simamora P; Alvarez JM; Yalkowsky SH
Int J Pharm; 2001 Feb; 213(1-2):25-9. PubMed ID: 11165091
[TBL] [Abstract][Full Text] [Related]
11. The effects of pH and mixed solvent systems on the solubility of oxytetracycline.
Tongaree S; Flanagan DR; Poust RI
Pharm Dev Technol; 1999; 4(4):571-80. PubMed ID: 10578512
[TBL] [Abstract][Full Text] [Related]
12. Solubility of nonelectrolytes in polar solvents IV: nonpolar drugs in mixed solvents.
Yalkowsky SH; Valvani SC; Amidon GL
J Pharm Sci; 1976 Oct; 65(10):1488-94. PubMed ID: 978408
[TBL] [Abstract][Full Text] [Related]
13. Influence of solute structure on deviations from the log-linear solubility equation in propylene glycol:water mixtures.
Rubino JT; Obeng EK
J Pharm Sci; 1991 May; 80(5):479-83. PubMed ID: 1880729
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical properties of binary organic cosolvent-water mixtures and their relationships to muscle damage following intramuscular injection.
Brazeau GA; Fung HL
J Parenter Sci Technol; 1989; 43(4):144-9. PubMed ID: 2769521
[TBL] [Abstract][Full Text] [Related]
15. Solubility of hydrophobic compounds in water-cosolvent mixtures: relation of solubility with water-cosolvent interactions.
Miyako Y; Zhao Y; Takeshima K; Kataoka T; Handa T; Pinal R
J Pharm Sci; 2010 Jan; 99(1):293-302. PubMed ID: 19548311
[TBL] [Abstract][Full Text] [Related]
16. Prediction of the optimized solvent composition for solubilization of drugs in water-cosolvent mixtures.
Jouyban A
Pharmazie; 2007 Mar; 62(3):190-8. PubMed ID: 17416195
[TBL] [Abstract][Full Text] [Related]
17. Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems.
Brazeau GA; Fung HL
Pharm Res; 1989 Sep; 6(9):766-71. PubMed ID: 2813273
[TBL] [Abstract][Full Text] [Related]
18. The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations.
Miller JM; Beig A; Carr RA; Webster GK; Dahan A
Mol Pharm; 2012 Mar; 9(3):581-90. PubMed ID: 22280478
[TBL] [Abstract][Full Text] [Related]
19. Solubility screening on a series of structurally related compounds: cosolvent-induced changes on the activity coefficient of hydrophobic solutes.
Miyako Y; Tai H; Ikeda K; Kume R; Pinal R
Drug Dev Ind Pharm; 2008 May; 34(5):499-505. PubMed ID: 18473232
[TBL] [Abstract][Full Text] [Related]
20. Solubilization of poorly soluble compounds using 2-pyrrolidone.
Jain P; Yalkowsky SH
Int J Pharm; 2007 Sep; 342(1-2):1-5. PubMed ID: 17570624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
